IBD tagged posts

Tiny Bubbles can be Future Treatment for Inflammation

Multimeric decoy receptor EV-sorting protein chimaera is functionalized on several EV subpopulations.

Scientists hope that tiny sacs of material excreted by cells — so-called extracellular vesicles — can be used to deliver drugs inside the body. Researchers at Karolinska Institutet now show that these nanobubbles can transport protein drugs that reduce inflammation caused by different diseases. The technique, which is presented in Nature Biomedical Engineering, shows promising results in animal models.

Extracellular vesicles (EVs) are important in inter-cellular communication as carriers of biological signals. They are nanometre-sized membrane-coated packages excreted by cells that can deliver fatty acids, proteins and genetic material to different tissues.

The tiny bubbles are f...

Read More

Novel Mechanism Links Genetic Defect in IBD Patients to Gut Leakiness

A team of researchers led by a biomedical scientist at the University of California, Riverside, has identified a novel mechanism by which loss-of-function mutations in the gene PTPN2, found in many patients with inflammatory bowel disease, or IBD, affect how intestinal epithelial cells maintain a barrier.

The intestinal epithelium, a single layer of cells, plays a critical role in human health by providing a barrier while also allowing nutrient and water absorption. Intestinal epithelial cells are needed for regulating immune function, communicating with the intestinal microbiota, and protecting the gut from pathogen infection – all of which critically depend on an intact epithelial barrier.

Affecting roughly 3 million Americans, IBD is a set of chronic intestinal diseases in wh...

Read More

IBD: Synthetic Hydrogels Deliver Cells to Repair Intestinal Injuries

Human intestinal organoids (HIOs) generated in the hydrogel matrix differentiate into mature intestinal tissue and present specialized human intestinal cell types, such as enteroendocrine cells (CHGA; red), after transplantation into an animal. Credit: Ricardo Cruz-Acuña, Georgia Tech

Human intestinal organoids (HIOs) generated in the hydrogel matrix differentiate into mature intestinal tissue and present specialized human intestinal cell types, such as enteroendocrine cells (CHGA; red), after transplantation into an animal. Credit: Ricardo Cruz-Acuña, Georgia Tech

By combining engineered polymeric materials known as hydrogels with complex intestinal tissue known as organoids – made from human pluripotent stem cells – researchers have taken an important step toward creating a new technology for controlling the growth of these organoids and using them for treating wounds in the gut that can be caused by disorders such as inflammatory bowel disease (IBD)...

Read More

Researchers help the Body Protect itself against Inflammation and Colon Cancer

Researchers help the body protect itself against inflammation and colon cancer

This image is a mouse intestinal organoid, or “mini-gut,” used to study epithelial cell barrier function in ongoing inflammatory bowel disease and cancer studies. Photo courtesy of Coy Allen. Credit: Virginia Tech

Could inflammatory bowel disease and colon cancer be prevented by changing the shape of a single protein? There is an intimate link between uncontrolled inflammation in the gut associated with inflammatory bowel disease and the eventual development of colon cancer. This uncontrolled inflammation is associated with changes in bacteria populations in the gut, which can invade the mucosal tissue after damage to the protective cellular barrier lining the tissue.
But Virginia Tech researchers found that modifying the shape of IRAK-M, a protein that controls inflammation, can significa...

Read More